tradingkey.logo
tradingkey.logo
Search

Cero Therapeutics Announces Tristar Centennial Medical Center As A Clinical Trial Site For Its Phase 1 Clinical Trial Of Cer-1236 In Acute Myeloid Leukemia

ReutersApr 30, 2025 12:19 PM
facebooktwitterlinkedin
View all comments0

- CERo Therapeutics Holdings Inc CERO.O:

  • CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES TRISTAR CENTENNIAL MEDICAL CENTER AS A CLINICAL TRIAL SITE FOR ITS PHASE 1 CLINICAL TRIAL OF CER-1236 IN ACUTE MYELOID LEUKEMIA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI